Anzeige
Meldung des Tages: Ein Deal läuft, der fast den gesamten Börsenwert übersteigt – und kaum jemand weiß es

Azenta News

Aktie
WKN:  257275 ISIN:  US1143401024 US-Symbol:  AZTA Branche:  Gesundheitswesen: Ausstattung u. Produkte Land:  USA
25,92 $
+0,81 $
+3,23%
22,097 € 24.04.26
Depot/Watchlist
Marktkapitalisierung *
-
Streubesitz
-
KGV
-22,27
Index-Zuordnung
Nasdaq Composite Index

Azenta News

07.04.26 - PR Newswire
Azenta Life Sciences Announces Leadership Transition to Accelerate Gene Synthesis Strategy and Multiomics Execution
Azenta Life Sciences Announces Leadership Transition to Accelerate Gene Synthesis Strategy and Multiomics Execution PR Newswire
04.03.26 - PR Newswire
Azenta Completes Strategic Acquisition of UK Biocentre Limited, to Expand Biorepository Capabilities
Azenta Completes Strategic Acquisition of UK Biocentre Limited, to Expand Biorepository Capabilities PR Newswire
24.02.26 - PR Newswire
Azenta to Participate in Raymond James 47th Annual Institutional Investor Conference
Azenta to Participate in Raymond James 47th Annual Institutional Investor Conference PR Newswire
09.02.26 - PR Newswire
Azenta Life Sciences and Frontier Space Announce Strategic Partnership to Advance Space-Based Life Sciences Research Infrastructure
Azenta Life Sciences and Frontier Space Announce Strategic Partnership to Advance Space-​Based Life Sciences Research Infrastructure PR Newswire
04.02.26 - PR Newswire
Azenta Reports First Quarter Results for Fiscal 2026, Ended December 31, 2025
Azenta Reports First Quarter Results for Fiscal 2026, Ended December 31, 2025 PR Newswire
21.01.26 - PR Newswire
Azenta Announces Fiscal 2026 First Quarter Conference Call and Webcast
Azenta Announces Fiscal 2026 First Quarter Conference Call and Webcast PR Newswire
29.12.25 - PR Newswire
Azenta Enters Definitive Agreement for the Sale of its B Medical Systems Business to THELEMA S.À R.L.
Azenta Enters Definitive Agreement for the Sale of its B Medical Systems Business to THELEMA S.À R.L. PR Newswire
10.12.25 - PR Newswire
Azenta Authorizes $250 Million Share Repurchase Program
Azenta Authorizes $250 Million Share Repurchase Program PR Newswire
21.11.25 - PR Newswire
Azenta Reports Fourth Quarter and Full Year Fiscal 2025 Results, Ended September 30, 2025
Azenta Reports Fourth Quarter and Full Year Fiscal 2025 Results, Ended September 30, 2025 PR Newswire
12.11.25 - PR Newswire
Azenta Announces Fiscal 2025 Fourth Quarter and Full Year Conference Call and Webcast
Azenta Announces Fiscal 2025 Fourth Quarter and Full Year Conference Call and Webcast PR Newswire
04.11.25 - PR Newswire
Azenta Life Sciences Partners with PRECEDE Foundation to Advance Early Detection of Pancreatic Cancer
Azenta Life Sciences Partners with PRECEDE Foundation to Advance Early Detection of Pancreatic Cancer PR Newswire
15.10.25 - PR Newswire
Azenta to Host Investor Day at its Biorepository Facility in Indianapolis, Indiana
Azenta to Host Investor Day at its Biorepository Facility in Indianapolis, Indiana PR Newswire
05.08.25 - PR Newswire
Azenta Reports Third Quarter Results for Fiscal 2025, Ended June 30, 2025; Reiterates Full Year Fiscal 2025 Guidance
Azenta Reports Third Quarter Results for Fiscal 2025, Ended June 30, 2025; Reiterates Full Year Fiscal 2025 Guidance PR Newswire
31.07.25 - PR Newswire
Fresenius Medical Care's Third-Party Clinical Research Organization Frenova Announces Strategic Collaboration Advancing Genomics-Driven, Precision Kidney Disease Care
Fresenius Medical Care's Third-​Party Clinical Research Organization Frenova Announces Strategic Collaboration Advancing Genomics-​Driven, Precision Kidney Disease Care PR ...
30.07.25 - PR Newswire
Azenta to Participate in 10th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference
Azenta to Participate in 10th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference PR Newswire
23.07.25 - PR Newswire
Azenta Announces Fiscal 2025 Third Quarter Earnings Conference Call and Webcast
Azenta Announces Fiscal 2025 Third Quarter Earnings Conference Call and Webcast PR Newswire
13.05.25 - PR Newswire
Azenta Life Sciences and Form Bio Announce Strategic Partnership to Advance AAV Gene Therapy Development
Azenta Life Sciences and Form Bio Announce Strategic Partnership to Advance AAV Gene Therapy Development PR Newswire
07.05.25 - PR Newswire
Azenta Reports Second Quarter Results for Fiscal 2025, Ended March 31, 2025
Azenta Reports Second Quarter Results for Fiscal 2025, Ended March 31, 2025 PR Newswire

Newssuche

Videos

newspaper
26.04.26
Big Fish Strategy Einführung
Strategie-​Paket inklusive Live-​Webinar am 3.5., Videoaufzeichnung, Unterlagen und Nachbetreuung JETZT ... Mehr »